CLINICAL_TRIALS ClinicalTrials.gov record update

Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00186342
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:24.274649+00:00
Published At: 2012-12-17T00:00:00+00:00
Record Updated At: 2012-12-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Disease", "Myelodysplastic Syndromes", "Leukemia, Myeloid, Chronic", "Myeloproliferative Disorders", "Blood and Marrow Transplant (BMT)", "Myelodysplastic Syndromes (MDS)", "Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2012-12-17"
protocolSection.identificationModule.nctId: "NCT00186342"
protocolSection.identificationModule.officialTitle: "Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.